Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Species | Mouse- BALB/C; Derived From: B13.29 (First Describ |
| Cat.No | ABC-TC210S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Hybridoma |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Myeloma Cell Lines |
The B9 cell line is a mouse B cell hybridoma, derived from the fusion of BALB/c spleen cells with SP2/0-AG14 myeloma cells. The B9 cells are primarily used for studying immune responses, including cytokine activity. Morphologically, B9 cells are small, round, and adhere to the surface in culture. These cells rely on Interleukin 6 (IL-6) for survival and proliferation and exhibit a dose-dependent response to lipopolysaccharide (LPS) stimulation. They also show sensitivity to hybridoma growth factor (HGF) and do not produce immunoglobulins. B9 cells maintain a stable genetic profile without notable mutations, and no high expression of special antigens or genes has been reported. In terms of tumorigenicity, B9 cells do not exhibit tumorigenic or metastatic properties. It is widely used in immunological assays and hybridoma technology for the study of cytokine function.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The B9 cell line serves as a valuable model for investigating the complex aspects of B cell biology and is used to study IL-6 in inflammatory, autoimmune, and cancer-related diseases. The B9 hybridoma enables a straightforward and highly sensitive assay, known as the B9 bioassay, for assessing IL-6 activity in human, rat, rabbit, pig, and mouse samples. This versatile cell line contributes to our understanding of epidermal regulation during the pathogenesis of various diseases.
